Highlights
NASDAQ: NBRV       Nabriva Therape Ads
Last Price Today's Change   Day's Range   Trading Volume
0.575   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):1,273,100
4 Weeks Range:0.51 - 0.62
4 Weeks Price Volatility (%):
92.74%
52 Weeks Range:0.485 - 2.23
52 Weeks Price Volatility (%):
25.78%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Nabriva Therapeutics AG is a clinical stage biopharmaceutical company. Nabriva is engaged in the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics. The company is developing product candidate, lefamulin, to be the first pleuromutilin antibiotic available for systemic administration in humans. It operates in one reportable segment, which comprises the research and development of novel anti-infective agents to treat serious infections.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

1311  4748  255  3158 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 HTZ 2.17-0.33 
 KXIN 8.15+6.08 
 LK 1.38+1.38 
 GE 7.290.00 
 AAPL 115.98-3.04 
 NIO 27.63-0.85 
 BIMI 2.68+0.74 
 OAS 0.155-0.014 
 SQQQ 21.85+1.01 
 AVP 5.60-0.05